vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and InvenTrust Properties Corp. (IVT). Click either name above to swap in a different company.
InvenTrust Properties Corp. is the larger business by last-quarter revenue ($77.4M vs $47.7M, roughly 1.6× IRONWOOD PHARMACEUTICALS INC). InvenTrust Properties Corp. runs the higher net margin — 3.4% vs -4.8%, a 8.2% gap on every dollar of revenue. On growth, InvenTrust Properties Corp. posted the faster year-over-year revenue change (8.6% vs -47.3%). InvenTrust Properties Corp. produced more free cash flow last quarter ($110.9M vs $74.6M). Over the past eight quarters, InvenTrust Properties Corp.'s revenue compounded faster (7.6% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
InvenTrust Properties Corp. is a real estate investment trust that invests in shopping malls. As of December 31, 2024, the company owned interests in 68 properties comprising 11.0 million square feet.
IRWD vs IVT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $77.4M |
| Net Profit | $-2.3M | $2.7M |
| Gross Margin | — | — |
| Operating Margin | 14.3% | -11.0% |
| Net Margin | -4.8% | 3.4% |
| Revenue YoY | -47.3% | 8.6% |
| Net Profit YoY | -200.9% | -72.8% |
| EPS (diluted) | $0.01 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.7M | $77.4M | ||
| Q3 25 | $122.1M | $74.5M | ||
| Q2 25 | $85.2M | $73.6M | ||
| Q1 25 | $41.1M | $73.8M | ||
| Q4 24 | $90.5M | $71.2M | ||
| Q3 24 | $91.6M | $68.5M | ||
| Q2 24 | $94.4M | $67.4M | ||
| Q1 24 | $74.9M | $66.8M |
| Q4 25 | $-2.3M | $2.7M | ||
| Q3 25 | $40.1M | $6.0M | ||
| Q2 25 | $23.6M | $95.9M | ||
| Q1 25 | $-37.4M | $6.8M | ||
| Q4 24 | $2.3M | $9.8M | ||
| Q3 24 | $3.6M | $-539.0K | ||
| Q2 24 | $-860.0K | $1.5M | ||
| Q1 24 | $-4.2M | $2.9M |
| Q4 25 | 14.3% | -11.0% | ||
| Q3 25 | 61.8% | -9.8% | ||
| Q2 25 | 53.2% | — | ||
| Q1 25 | -70.7% | -10.5% | ||
| Q4 24 | 34.8% | -3.6% | ||
| Q3 24 | 28.0% | -18.7% | ||
| Q2 24 | 26.5% | -13.6% | ||
| Q1 24 | 14.7% | -13.1% |
| Q4 25 | -4.8% | 3.4% | ||
| Q3 25 | 32.8% | 8.1% | ||
| Q2 25 | 27.7% | 130.4% | ||
| Q1 25 | -90.9% | 9.2% | ||
| Q4 24 | 2.5% | 13.8% | ||
| Q3 24 | 4.0% | -0.8% | ||
| Q2 24 | -0.9% | 2.2% | ||
| Q1 24 | -5.6% | 4.3% |
| Q4 25 | $0.01 | $0.02 | ||
| Q3 25 | $0.23 | $0.08 | ||
| Q2 25 | $0.14 | $1.23 | ||
| Q1 25 | $-0.23 | $0.09 | ||
| Q4 24 | $0.03 | $0.14 | ||
| Q3 24 | $0.02 | $-0.01 | ||
| Q2 24 | $-0.01 | $0.02 | ||
| Q1 24 | $-0.03 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | — |
| Total DebtLower is stronger | — | $825.9M |
| Stockholders' EquityBook value | $-261.8M | $1.8B |
| Total Assets | $396.9M | $2.8B |
| Debt / EquityLower = less leverage | — | 0.46× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.5M | — | ||
| Q3 25 | $140.4M | — | ||
| Q2 25 | $92.9M | — | ||
| Q1 25 | $108.5M | — | ||
| Q4 24 | $88.6M | — | ||
| Q3 24 | $88.2M | — | ||
| Q2 24 | $105.5M | — | ||
| Q1 24 | $121.5M | — |
| Q4 25 | — | $825.9M | ||
| Q3 25 | $199.5M | $764.6M | ||
| Q2 25 | $199.3M | $746.3M | ||
| Q1 25 | $199.2M | $740.7M | ||
| Q4 24 | $199.0M | $740.4M | ||
| Q3 24 | $198.8M | $740.1M | ||
| Q2 24 | $198.6M | $812.2M | ||
| Q1 24 | $398.3M | $827.5M |
| Q4 25 | $-261.8M | $1.8B | ||
| Q3 25 | $-264.2M | $1.8B | ||
| Q2 25 | $-308.2M | $1.8B | ||
| Q1 25 | $-334.1M | $1.7B | ||
| Q4 24 | $-301.3M | $1.8B | ||
| Q3 24 | $-311.3M | $1.8B | ||
| Q2 24 | $-321.7M | $1.5B | ||
| Q1 24 | $-330.5M | $1.5B |
| Q4 25 | $396.9M | $2.8B | ||
| Q3 25 | $396.1M | $2.7B | ||
| Q2 25 | $342.9M | $2.7B | ||
| Q1 25 | $327.2M | $2.6B | ||
| Q4 24 | $350.9M | $2.6B | ||
| Q3 24 | $389.5M | $2.6B | ||
| Q2 24 | $395.6M | $2.5B | ||
| Q1 24 | $438.8M | $2.5B |
| Q4 25 | — | 0.46× | ||
| Q3 25 | — | 0.42× | ||
| Q2 25 | — | 0.41× | ||
| Q1 25 | — | 0.42× | ||
| Q4 24 | — | 0.42× | ||
| Q3 24 | — | 0.42× | ||
| Q2 24 | — | 0.53× | ||
| Q1 24 | — | 0.53× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $155.4M |
| Free Cash FlowOCF − Capex | $74.6M | $110.9M |
| FCF MarginFCF / Revenue | 156.3% | 143.3% |
| Capex IntensityCapex / Revenue | 0.0% | 57.5% |
| Cash ConversionOCF / Net Profit | — | 58.41× |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | $193.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $155.4M | ||
| Q3 25 | $47.6M | $43.8M | ||
| Q2 25 | $-15.1M | $48.7M | ||
| Q1 25 | $20.0M | $20.2M | ||
| Q4 24 | $15.2M | $136.9M | ||
| Q3 24 | $9.9M | $38.4M | ||
| Q2 24 | $33.5M | $46.7M | ||
| Q1 24 | $45.0M | $14.8M |
| Q4 25 | $74.6M | $110.9M | ||
| Q3 25 | $47.6M | $31.4M | ||
| Q2 25 | $-15.1M | $38.0M | ||
| Q1 25 | $19.9M | $12.8M | ||
| Q4 24 | — | $100.8M | ||
| Q3 24 | $9.9M | $29.3M | ||
| Q2 24 | $33.4M | $37.2M | ||
| Q1 24 | $44.9M | $7.7M |
| Q4 25 | 156.3% | 143.3% | ||
| Q3 25 | 39.0% | 42.2% | ||
| Q2 25 | -17.7% | 51.6% | ||
| Q1 25 | 48.4% | 17.4% | ||
| Q4 24 | — | 141.5% | ||
| Q3 24 | 10.8% | 42.8% | ||
| Q2 24 | 35.4% | 55.2% | ||
| Q1 24 | 60.0% | 11.5% |
| Q4 25 | 0.0% | 57.5% | ||
| Q3 25 | 0.0% | 16.7% | ||
| Q2 25 | 0.0% | 14.6% | ||
| Q1 25 | 0.1% | 10.0% | ||
| Q4 24 | 0.0% | 50.7% | ||
| Q3 24 | 0.0% | 13.3% | ||
| Q2 24 | 0.1% | 14.0% | ||
| Q1 24 | 0.1% | 10.6% |
| Q4 25 | — | 58.41× | ||
| Q3 25 | 1.19× | 7.27× | ||
| Q2 25 | -0.64× | 0.51× | ||
| Q1 25 | — | 2.97× | ||
| Q4 24 | 6.74× | 13.97× | ||
| Q3 24 | 2.71× | — | ||
| Q2 24 | — | 31.15× | ||
| Q1 24 | — | 5.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
